All Posts

Glaucoma is a leading cause of irreversible vision loss worldwide. Many people do not realize they have it until significant damage has occurred. Early detection and effective management are crucial to preserving sight. Thanks to advances in technology like the REVO OCT and therapeutic options such as glaucoma eye drops, managing this condition has become more precise and personalized.

Children often do not realise they have vision problems because they assume everyone sees the world the same way. Vision testing helps identify issues that might affect their ability to read, write, and participate in activities. Early detection is key to preventing long-term problems.

PSG Eyeware has partnered with trusted manufacturers to offer safety glasses that meet industry standards and accommodate prescription lenses.

The Revo OCT FC uses optical coherence tomography (OCT) technology to create high-resolution cross-sectional images of the retina. This allows eye care professionals to detect subtle changes in retinal layers that indicate diseases such as glaucoma and age-related macular degeneration (AMD).

Macular degeneration affects millions worldwide, causing gradual vision loss that impacts daily life. Early detection and effective management are crucial to slowing its progression. Two tools gaining attention for their role in this fight are the REVO OCT imaging system and MDEyes supplements based on the AREDS 2 formula. This post explores how these technologies work together to support eye health and help manage macular degeneration.